In a study on the construction of a mouse model of idiopathic pulmonary fibrosis based on bleomycin (BLM), Astragalus polysaccharide was found to attenuate the inflammatory response by inhibiting the TLR4/NF-κB signaling pathway [57]. Here, TLR4 is linked to idiopathic pulmonary fibrosis.